Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Financial Flexibility Index
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥112.14 Million (operating CF CN¥39.68 Million minus capex CN¥72.46 Million) represents 0% of total liabilities (CN¥2.99 Billion). Also explore net asset momentum of Xizang Haisco Pharmaceutical Group Co Lt to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Xizang Haisco Pharmaceutical Group Co Ltd across 17 annual periods. Check Xizang Haisco Pharmaceutical Group Co Lt strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2024)
Year-by-year free cash flow to debt coverage for Xizang Haisco Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 002653 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.34x | CN¥882.70 Million | CN¥442.05 Million | CN¥2.60 Billion | ▲ +0.4% |
| 2023 | 0.34x | CN¥840.59 Million | CN¥449.58 Million | CN¥2.48 Billion | ▲ +24.1% |
| 2022 | 0.27x | CN¥794.71 Million | CN¥94.55 Million | CN¥2.91 Billion | ▼ -23.0% |
| 2021 | 0.35x | CN¥738.74 Million | CN¥35.80 Million | CN¥2.09 Billion | ▼ -6.1% |
| 2020 | 0.38x | CN¥807.93 Million | CN¥206.21 Million | CN¥2.14 Billion | ▼ -25.5% |
| 2019 | 0.51x | CN¥1.35 Billion | CN¥764.26 Million | CN¥2.66 Billion | ▲ +45.7% |
| 2018 | 0.35x | CN¥824.59 Million | CN¥472.61 Million | CN¥2.37 Billion | ▼ -5.3% |
| 2017 | 0.37x | CN¥785.07 Million | CN¥391.81 Million | CN¥2.14 Billion | ▼ -16.1% |
| 2016 | 0.44x | CN¥634.35 Million | CN¥426.11 Million | CN¥1.45 Billion | ▼ -35.5% |
| 2015 | 0.68x | CN¥726.70 Million | CN¥443.03 Million | CN¥1.07 Billion | ▼ -29.4% |
| 2014 | 0.96x | CN¥737.43 Million | CN¥502.57 Million | CN¥767.55 Million | ▼ -30.4% |
| 2013 | 1.38x | CN¥732.40 Million | CN¥568.41 Million | CN¥530.24 Million | ▼ -44.2% |
| 2012 | 2.47x | CN¥590.05 Million | CN¥464.75 Million | CN¥238.49 Million | ▼ -24.9% |
| 2011 | 3.29x | CN¥378.52 Million | CN¥260.79 Million | CN¥114.95 Million | ▲ +29.9% |
| 2010 | 2.54x | CN¥448.33 Million | CN¥367.38 Million | CN¥176.79 Million | ▲ +38.5% |
| 2009 | 1.83x | CN¥392.22 Million | CN¥368.21 Million | CN¥214.22 Million | ▲ +92.7% |
| 2008 | 0.95x | CN¥131.82 Million | CN¥94.45 Million | CN¥138.73 Million | — |